GLP-1

Retatrutide Dosing Guide — 2mg to 12mg Titration Protocol

March 28, 2026
11 min read
Share this article
The Bottom Line
Retatrutide (commonly called "reta") dosing follows a titration schedule starting at 2mg/week and escalating to a maximum of 12mg/week over 20+ weeks. The standard protocol increases every 4 weeks: 2mg, 4mg, 6mg, 8mg, 10mg, 12mg. Not everyone needs to reach 12mg — Phase 3 data shows significant weight loss at 8mg and 9mg as well. Many users split their weekly dose into 2-3 smaller injections to reduce nausea and smooth out blood levels. Use our free GLP-1 dose calculator to calculate exact units for any dose, and our split-dose calculator if you're dividing your weekly dose across multiple injections.

What Dose Should You Start At?

Retatrutide (LY3437943) is a triple hormone receptor agonist that activates GLP-1, GIP, and glucagon receptors simultaneously. Due to the glucagon receptor component — which is not present in tirzepatide ("tirz") or semaglutide — all dosing protocols start at the lowest tier regardless of prior GLP-1 experience.

The starting dose is 2mg/week for the first 4 weeks. This applies even if you are switching from tirzepatide at 15mg/week. The glucagon receptor activation introduces pharmacological effects your body has not been exposed to, and starting higher significantly increases the risk of severe nausea, vomiting, and GI distress.

Important
Retatrutide is in Phase 3 clinical trials and is not FDA-approved. The dosing information in this guide is based on published Phase 2 and Phase 3 clinical trial protocols and community experience. This is for educational purposes only. Work with a licensed healthcare provider for dosing decisions and monitoring.

Standard Titration Schedule (Clinical Trial Protocol)

This schedule is based on the dosing arms used in retatrutide Phase 2 and Phase 3 clinical trials. Each tier lasts a minimum of 4 weeks:

PhaseWeeksDosePurpose
ToleranceWeeks 1-42 mg/weekAssess GI tolerance to triple-receptor activation
Early therapeuticWeeks 5-84 mg/weekFirst meaningful appetite suppression begins
IntermediateWeeks 9-126 mg/weekGlucagon effects become more noticeable — increased energy expenditure
Higher therapeuticWeeks 13-168 mg/weekSignificant weight loss acceleration
Near-maximumWeeks 17-2010 mg/weekApproaching maximum studied dose
MaximumWeek 21+12 mg/weekHighest dose studied in Phase 2/3 trials
Pro Tip
Not everyone needs to reach 12mg. In Phase 3 trials, the 9mg group achieved 26.4% average weight loss — only 2.3 percentage points less than the 12mg group. If you're achieving good weight loss at 6-8mg with manageable side effects, there may be no reason to push higher. The principle is the same as with semaglutide and tirzepatide: increase only if weight loss has meaningfully stalled AND you're tolerating the current dose well.

Community Titration Approaches

The clinical trial protocol increases dose every 4 weeks. In practice, many providers and experienced users take a different approach:

Slower Titration (5-6 Weeks Per Tier)

Staying longer at each dose — particularly at 4mg and 6mg — reduces the intensity of GI side effects. The body adapts to each dose level more completely before adding more receptor stimulation. There is no clinical penalty for titrating slowly. Your body reaches the same steady-state levels — just with fewer days of intense nausea.

The 6mg to 8mg Wall

Community reports consistently flag the jump from 6mg to 8mg as the hardest transition. This is where glucagon receptor effects intensify most noticeably — nausea, reduced appetite (sometimes to the point of difficulty eating enough), and increased body heat. Strategies for this transition:

  • Split the 8mg dose into two 4mg injections (see split dosing section below)
  • Stay at 6mg for 6-8 weeks instead of 4
  • Increase to 7mg first (possible with compounded vials) before jumping to 8mg

Lower Maintenance Doses

Some users find their optimal dose is 6mg or 8mg and stay there long-term rather than pushing to 12mg. If you're losing 1-2 lbs/week consistently at 8mg, increasing to 12mg adds more side effects without proportionally more weight loss. Find your effective dose and stay there.

Community Insight
A common pattern in community discussions: users who rushed to 12mg often end up reducing back to 8mg because the side effects aren't worth the marginal extra weight loss. Users who titrated slowly and found their "sweet spot" at 6-8mg tend to stay on protocol longer with better adherence. Slower is usually better with reta.

Split Dosing and Microdosing Protocols

Split dosing means dividing your weekly dose into smaller, more frequent injections. Instead of 8mg once per week, you'd inject 4mg twice per week (e.g., Monday and Thursday). This approach is increasingly popular with retatrutide because the glucagon receptor activation produces a sharper nausea spike at peak blood levels than tirzepatide.

Why Split Dosing Works

  • Lower peak blood levels = less nausea in the 24-48 hours after injection
  • Higher trough levels = more consistent appetite suppression throughout the week
  • Retatrutide's half-life is ~6 days (144 hours), which means once-weekly dosing produces significant peaks and troughs

Common Split-Dose Protocols

ProtocolScheduleExample (8mg/week total)Best For
Twice weeklyMon + Thu4mg + 4mgMost popular; good balance of convenience and smoothing
Three times weeklyMon + Wed + Fri2.7mg + 2.7mg + 2.7mgMaximum stability; lowest peaks
Every other dayEOD~2.3mg per injectionBalance of smoothing and simplicity

How to Calculate Split Doses

  1. Determine your total weekly dose (e.g., 8mg)
  2. Divide by number of injections (8mg / 2 = 4mg per injection)
  3. Use the GLP-1 dose calculator to convert mg to units for your specific vial concentration
  4. Or use the split-dose calculator which does all of this automatically
Pro Tip
If you're currently doing once-weekly and experiencing bad nausea days, try switching to twice-weekly at the same total dose before increasing your dose. Many users find that twice-weekly at 8mg total is more tolerable than once-weekly at 6mg — they get a higher dose with fewer side effects by smoothing the peaks.
Community Insight
The microdosing approach is especially popular among users who train regularly. By keeping blood levels more stable, they avoid the "crash day" (usually 24-36 hours post-injection) where nausea and fatigue make training difficult. With split dosing, most users report being able to train every day without a predictable bad day each week.

Track every retatrutide dose, weight trend, and side effect in one app

  • Log reta doses with pharmacokinetic blood level modeling
  • Track weight moving averages and body composition
  • Monitor side effects at each titration tier
Regimen peptide and GLP-1 tracker app screenshot

How to Calculate Your Dose

The formula for all reconstituted peptides:

Units to draw = (Target dose in mg / Concentration in mg/mL) x 100

Concentration = Total peptide in vial (mg) / BAC water added (mL)

Worked example:

12mg retatrutide vial + 2mL BAC water = 6.0 mg/mL

Target: 4mg/week

Units = (4 / 6.0) x 100 = 66.7 — draw 67 units

Or skip the math: GLP-1 Dose Calculator

For split dosing, just divide: 4mg split into two injections = 2mg each = 33 units per injection.

Dose Charts by Vial Size

5mg Vial + 1mL BAC Water (5.0 mg/mL)

Weekly DoseUnits to DrawWeeks Per Vial
2 mg40 units2.5 weeks
4 mg80 units1.25 weeks

Best for: First 4-8 weeks of titration (2-4mg doses)

12mg Vial + 2mL BAC Water (6.0 mg/mL)

Weekly DoseUnits to DrawWeeks Per Vial
2 mg33 units6 weeks
4 mg67 units3 weeks
6 mg100 units2 weeks

Best for: Titration through 2-6mg range

30mg Vial + 2mL BAC Water (15.0 mg/mL)

Weekly DoseUnits to DrawWeeks Per Vial
4 mg27 units7.5 weeks
6 mg40 units5 weeks
8 mg53 units3.75 weeks
10 mg67 units3 weeks
12 mg80 units2.5 weeks

Best for: Maintenance dosing at 6mg+ (finishes within 28-day stability window)

Important
Reconstituted retatrutide is stable for approximately 28 days refrigerated. Match your vial size to your current dose so you finish the vial within 4 weeks. A 30mg vial at 2mg/week would last 15 weeks on paper — but the peptide degrades well before that. Use a 5mg or 12mg vial during early titration, then switch to 30mg once you're at 6mg+ weekly.

For detailed reconstitution instructions, see our complete Retatrutide Reconstitution Calculator Guide.

Half-Life and Injection Timing

Retatrutide has a half-life of approximately 6 days (144 hours). Key implications:

  • Steady state is reached within 4-5 weeks at any given dose
  • Once-weekly dosing is supported by the half-life, but produces noticeable peaks and troughs
  • Best injection day/time: Most users inject in the evening so that peak nausea (usually 12-36 hours post-injection) occurs during sleep and the following day, with recovery by the second evening
  • Consistency matters: Inject on the same day(s) each week at approximately the same time

Use our half-life visualizer to see how retatrutide blood levels change throughout the week at different dose frequencies.

When to Increase Your Dose

Increase your dose only when ALL of these are true:

  1. You've been at the current dose for at least 4 weeks (preferably 5-6)
  2. Weight loss has stalled for 2+ weeks (less than 0.5 lbs/week)
  3. You're tolerating the current dose well (nausea is minimal or gone)
  4. You're eating adequate protein (1.2-1.6g/kg/day) and not over-restricting calories
  5. You're not experiencing significant side effects that would worsen with a higher dose

When NOT to Increase Your Dose

Do NOT increase if:

  • You're still losing weight consistently at the current dose (even if it's "only" 1 lb/week — that's 52 lbs/year)
  • You're experiencing persistent nausea, vomiting, or GI issues
  • Your resting heart rate has increased more than 15 bpm from baseline
  • You haven't been at the current dose for at least 4 full weeks
  • You're not eating enough (undereating + dose increase = muscle loss and metabolic adaptation)
Pro Tip
Track your weight in a 7-day moving average, not daily weigh-ins. Daily weight fluctuates 2-5 lbs based on water, sodium, and food volume. A stall is only real if the 7-day average has been flat for 2+ consecutive weeks. The Regimen app shows your moving average automatically.

Tracking Your Dosing Protocol

What to track at each dose tier:

  • Dose amount and timing (especially if split dosing)
  • Weight (daily or every other day for accurate moving averages)
  • Side effects with severity ratings (nausea, appetite, energy, GI)
  • Resting heart rate (check weekly — retatrutide can increase it 5-12 bpm)
  • Protein intake (aim for 1.2-1.6g/kg — track in any food app and log in Regimen)
  • Body measurements and progress photos (weight alone doesn't capture body composition changes)

The Regimen app tracks retatrutide alongside all your other compounds with pharmacokinetic blood level modeling, so you can see exactly where your levels are throughout the week — especially useful if you're split dosing.

Frequently Asked Questions

Disclaimer: This article is for educational purposes only and is not medical advice. Retatrutide is not FDA-approved and is currently in Phase 3 clinical trials. The dosing protocols described here are based on published clinical trial data and community experience. Always work with a licensed healthcare provider for dosing decisions and monitoring. Individual responses vary significantly.

Ready to track your protocol?

  • Smart reminders so you never miss a dose
  • Track weight, photos, and progress over time
  • Medication level curves for every compound
Regimen peptide and GLP-1 tracker app screenshot
Share this article

Related Articles